These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats. Zeng S; Zhou X; Tu Y; Yao M; Han ZQ; Gao F; Li YM Clin Exp Hypertens; 2011; 33(5):316-24. PubMed ID: 21649529 [TBL] [Abstract][Full Text] [Related]
27. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243 [TBL] [Abstract][Full Text] [Related]
28. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress. da Costa CA; de Oliveira PR; de Bem GF; de Cavalho LC; Ognibene DT; da Silva AF; Dos Santos Valença S; Pires KM; da Cunha Sousa PJ; de Moura RS; Resende AC Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec; 385(12):1199-209. PubMed ID: 23052352 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. León H; Baczkó I; Sawicki G; Light PE; Schulz R Br J Pharmacol; 2008 Feb; 153(4):676-83. PubMed ID: 18071296 [TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Neto-Neves EM; Sousa-Santos O; Ferraz KC; Rizzi E; Ceron CS; Romano MM; Gali LG; Maciel BC; Schulz R; Gerlach RF; Tanus-Santos JE J Cell Mol Med; 2013 Dec; 17(12):1588-97. PubMed ID: 24199964 [TBL] [Abstract][Full Text] [Related]
31. Loss of dystrophin is associated with increased myocardial stiffness in a model of left ventricular hypertrophy. Donato M; Buchholz B; Morales C; Valdez L; Zaobornyj T; Baratta S; Paez DT; Matoso M; Vaccarino G; Chejtman D; Agüero O; Telayna J; Navia J; Hita A; Boveris A; Gelpi RJ Mol Cell Biochem; 2017 Aug; 432(1-2):169-178. PubMed ID: 28316061 [TBL] [Abstract][Full Text] [Related]
32. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy. Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278 [TBL] [Abstract][Full Text] [Related]
33. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function. da Rocha EV; Falchetti F; Pernomian L; de Mello MMB; Parente JM; Nogueira RC; Gomes BQ; Bertozi G; Sanches-Lopes JM; Tanus-Santos JE; Castro MM Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):939-949. PubMed ID: 36527481 [TBL] [Abstract][Full Text] [Related]
35. Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy. Rodriguez WE; Tyagi N; Deng AY; Adeagbo A; Joshua IG; Tyagi SC Arch Physiol Biochem; 2008 Dec; 114(5):340-8. PubMed ID: 19003589 [TBL] [Abstract][Full Text] [Related]
36. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats. Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513 [TBL] [Abstract][Full Text] [Related]
37. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension. Siciliano M; Mettimano M; Dondolini-Poli A; Ballarin S; Migneco A; Annese R; Fazzari L; Fedeli P; Montebelli MR; Zuppi C; Savi L Ital Heart J; 2000 Aug; 1(8):532-5. PubMed ID: 10994933 [TBL] [Abstract][Full Text] [Related]
38. Doxycycline attenuates isoproterenol-induced myocardial fibrosis and matrix metalloproteinase activity in rats. Hori Y; Kunihiro S; Sato S; Yoshioka K; Hara Y; Kanai K; Hoshi F; Itoh N; Higuchi S Biol Pharm Bull; 2009 Oct; 32(10):1678-82. PubMed ID: 19801827 [TBL] [Abstract][Full Text] [Related]
39. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. Antonio RC; Ceron CS; Rizzi E; Coelho EB; Tanus-Santos JE; Gerlach RF Mol Cell Biochem; 2014 Jan; 386(1-2):99-105. PubMed ID: 24114660 [TBL] [Abstract][Full Text] [Related]
40. Hypertension, augmented activity of matrix metalloproteinases-2 and -9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline. Nascimento RA; Possomato-Vieira JS; Gonçalves-Rizzi VH; Bonacio GF; Rizzi E; Dias-Junior CA Eur J Pharmacol; 2018 Dec; 840():60-69. PubMed ID: 30336141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]